Sign in
4

Changes in Ownership

AYTU BIOPHARMA, INC Filed Acc 0001437749-25-030648

Chief Business Officer acquired 32,106 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Disbrow Jarrett · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-10-03 Grant or award : show line 1 in the form +19,606 49,068 D
2025-10-03 Grant or award : show line 2 in the form +12,500 61,568 D
Loading xslF345X05/rdgdoc.xml…